SCHEMBL22708443

SCHEMBL22708443

c1ccc(-c2ccc3c(ccc4oc5c(ccc6[nH]c7ccccc7c65)c43)c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK4 P11802 6/20 0.47
▸ CCND1 P24385 6/20 0.47
▸ GABRP O00591 1/20 0.42
▸ GABRD O14764 1/20 0.42
▸ GABRA1 P14867 1/20 0.42
▸ GABRB1 P18505 1/20 0.42
▸ GABRG2 P18507 1/20 0.42
▸ GABRB3 P28472 1/20 0.42
▸ GABRA5 P31644 1/20 0.42
▸ GABRA3 P34903 1/20 0.42
▸ GABRA2 P47869 1/20 0.42
▸ GABRB2 P47870 1/20 0.42
▸ GABRA4 P48169 1/20 0.42
▸ GABRE P78334 1/20 0.42
▸ GABRA6 Q16445 1/20 0.42
▸ GABRG1 Q8N1C3 1/20 0.42
▸ GABRG3 Q99928 1/20 0.42
▸ GABRQ Q9UN88 1/20 0.42
▸ PGR P06401 1/20 0.40
▸ KDM4E B2RXH2 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22708477 0.86 KIF11 (0.44) CDK4CCND1GABRPGABRDGABRA1
SCHEMBL16482161 0.86 GABRP (0.45) CDK4CCND1GABRPGABRDGABRA1
SCHEMBL14951574 0.85 CDK4 (0.48) CDK4CCND1GABRPGABRDGABRA1
SCHEMBL19432956 0.85 CDK4 (0.61) CDK4CCND1GABRPGABRDGABRA1
SCHEMBL25681346 0.84 GABRP (0.46) CDK4CCND1GABRPGABRDGABRA1
SCHEMBL19266660 0.84 CDK4 (0.59) CDK4CCND1GABRPGABRDGABRA1
SCHEMBL22708418 0.82 HPGD (0.45) CDK4CCND1GABRPGABRDGABRA1
SCHEMBL22708395 0.81 CDK4 (0.48) CDK4CCND1GABRPGABRDGABRA1
SCHEMBL21427506 0.80 CDK4 (0.46) CDK4CCND1GABRPGABRDGABRA1
SCHEMBL19432958 0.80 CASP3 (0.47) CDK4CCND1GABRPGABRDGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588110-B2 Heterocyclic compound and organic light emitting device comprising the same LT MATERIALS CO., LTD. (KR) 2023-02-21 — — US disclosed
US-20200373499-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LT MATERIALS CO., LTD. (KR) 2020-11-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11588110-B2 Heterocyclic compound and organic light emitting device comprising the same CRY1, CYP1A1, CYP1B1 CDK4 185/4885CCND1 114/4885GABRP 4220/4885
US-20200373499-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY1, CYP1A1, CYP1B1 CDK4 185/4885CCND1 114/4885GABRP 4220/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback